Tara Draehn
Family · Willis, TXNPI 1194315739
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,524 of the $35,025 with a category attached, or 61.5%. AbbVie accounts for 66.3% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2023 at $16,656 and has fallen 72.6% since, to $4,565 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $98.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$23K
- Spinal Simplicity, LLC$4K
- Surgentec$2K
- Relievant Medsystems, Inc.$1K
- Pacira Pharmaceuticals Incorporated$765
- GRT US Holding, Inc.$509
- plus $3K from 31 others
What the payments were for
- Consulting fees$2,6257%
- Speaking & faculty fees$21,52461%
- Travel & lodging$2,0906%
- Food & beverage$7,17320%
- Education$1,6135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$21,648
- QULIPTA$13,986
- HA MINUTEMAN G3-R$3,488
- Intracept$1,906
- ION Facet Screw$1,801
- Iovera$652
- ION Facet Screw System$488
- TiLink$488
- Qutenza$367
- iFuse Implant$297
- Repatha$125
- SUPERION$111
- Evoke$108
How this compares
$35,025 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 21 | $15,104 |
| Gabapentin | 130 | $1,287 |
| Pregabalin | 16 | $393 |
| Cyclobenzaprine Hcl | 53 | $341 |
| Tizanidine Hcl | 40 | $197 |
| Levothyroxine Sodium | 13 | $80 |
| Tramadol Hcl | 24 | $72 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $68 |
| Meloxicam | 25 | $42 |
| Prednisone | 20 | $37 |
| Diazepam | 12 | $6 |
Paid to pharmacies, not to this prescriber.
Other family in Willis
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.